Amanote Research
Register
Sign In
Cyclooxygenase-2 Is an Independent Prognostic Factor in Gastric Cancer and Its Expression Is Regulated by the Messenger RNA Stability Factor HuR
Clinical Cancer Research
- United States
doi 10.1158/1078-0432.ccr-05-0764
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
October 15, 2005
Authors
J. Mrena
Publisher
American Association for Cancer Research (AACR)
Related search
Full-Length Telomerase Reverse Transcriptase Messenger RNA Is an Independent Prognostic Factor in Neuroblastoma
American Journal of Pathology
Forensic Medicine
Pathology
Altered Expression of the mRNA Stability Factor HuR Promotes Cyclooxygenase-2 Expression in Colon Cancer Cells
Journal of Clinical Investigation
Medicine
Prognostic Nutritional Index Is an Independent Prognostic Factor for Gastric Cancer Patients With Peritoneal Dissemination
Chinese Journal of Cancer Research
Cancer Research
Oncology
Abnormal Fhit Expression Is an Independent Poor Prognostic Factor for Cervical Cancer
British Journal of Cancer
Cancer Research
Oncology
EphA4 Is a Prognostic Factor in Gastric Cancer
BMC Clinical Pathology
Forensic Medicine
Pathology
Histology
Cytoplasmic Expression of HuR Is Related to Cyclooxygenase-2 Expression in Colon Cancer
Cancer Research and Treatment
Cancer Research
Oncology
The Multifunctional Protein Glyceraldehyde-3-Phosphate Dehydrogenase Is Both Regulated and Controls Colony-Stimulating Factor-1 Messenger RNA Stability in Ovarian Cancer
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
Decreased Expression of Eukaryotic Initiation Factor 3f Is an Adverse Prognostic Factor for Stage I–III Gastric Cancer
World Journal of Surgical Oncology
Surgery
Oncology
Met Expression Is an Independent Prognostic Risk Factor in Patients With Oesophageal Adenocarcinoma
British Journal of Cancer
Cancer Research
Oncology
